{"id":7793,"date":"2023-03-01T08:00:22","date_gmt":"2023-03-01T13:00:22","guid":{"rendered":"https:\/\/americacellbank.com\/sin-categorizar\/mesenchymal-stem-cell-exosomes-resistance-to-cancer-therapy"},"modified":"2024-08-14T09:24:39","modified_gmt":"2024-08-14T14:24:39","slug":"mesenchymal-stem-cell-exosomes-resistance-to-cancer-therapy","status":"publish","type":"post","link":"https:\/\/americacellbank.com\/en\/mesenchymal-stem-cell-exosomes-resistance-to-cancer-therapy\/","title":{"rendered":"Mesenchymal stem cell exosomes: resistance to cancer therapy."},"content":{"rendered":"\n

Let’s remember… What are exosomes?<\/strong><\/p>\n\n

Exosomes<\/strong>, which are a tiny bag-like structure that forms inside a cell and contains some of the cellular proteins as well as portions of the cell’s DNA<\/strong> and RNA<\/strong>, act as proteins for some cells and are information carriers for others.<\/p>\n\n

Great potential of exosomes in cancer therapy<\/strong><\/p>\n\n

It should be emphasized that cancer is a major disease and the leading cause of mortality worldwide.\nAlthough various treatment approaches, such as surgery, chemotherapy, radiotherapy, targeted therapy and immunotherapy, have been developed and have effectively improved patient prognoses, both intrinsic and acquired resistance to therapy contribute to reduced therapeutic efficacy, resulting in poor cancer patient outcomes. <\/p>\n\n

Very recent work has shown that mesenchymal stem cell-derived exosomes<\/a> are critically involved in cancer resistance to chemotherapy agents, targeted therapy drugs, radiotherapy and immunotherapy.\nThese exosomes have been exploited as a new therapeutic strategy in anti-tumor treatment due to their various advantages, such as biocompatibility, promising potential for modification and lack of cytotoxicity. <\/p>\n\n

Mesenchymal stem cell exosomes are evaluated in:<\/strong><\/h2>\n\n